The present study examined 2008 global publications on Withania somnifera, as indexed and covered in international Scopus database during 1995-2018, with a view to understand their publications growth rate, global publication share, citation impact, share of their international collaborative publications, distribution of publications by broad subjects, productivity and citation profile of top organizations and authors, preferred media of communication and bibliographic characteristics of high cited publications. The global publications registered 18.31% annual average growth rate and its citation impact averaged to 18.55 citations per publication. The global share of top 10 countries ranged from 1.34% to 70.42%, with the largest share (70.42%) from India, followed by USA (11.35%) and other 8 countries from 1.34% to 4.03%. More than 100% of the cumulative global publication and citation share comes from top 10 countries during 1995-18. Only four countries among top 10 registered relative citation index above the world aver-
INTRODUCTION
Withania somnifera (WS), also known as ashwagandha, Indian ginseng, and winter cherry, it has been an important herb in the Ayurvedic and indigenous medical systems for over 3000 years. 1 Withania somnifera is an important medicinal plant of the Indian subcontinent. It is widely used, singly or in combination, with other herbs against many ailments in Indian Systems of Medicine since time immemorial. WS is a small, woody shrub in the Solanaceae family that grows about two feet in height. It can be found growing in Africa, the Mediterranean, and India. Its whole plant, roots, leaves, stem, green berries, fruits, seeds, bark are used. An erect, evergreen, tomentose shrub, 30-150 cm high, found throughout the drier parts of India in waste places and on bunds. Roots are stout fleshy, whitish brown; leaves simple ovate, glabrous, those in the floral region smaller and opposite; flowers inconspicuous, greenish or lubrid-yellow, in axillary, umbellate cymes; berries small, globose, orange-red when mature, enclosed in the persistent calyx; seeds yellow, reniform. 2 The roots of the plant are categorised as rasayanas, which are reputed to promote health and longevity by augmenting defence against disease, arresting the ageing process, revitalising the body in debilitated conditions, increasing the capability of the individual to resist adverse environmental factors and by creating a sense of mental well-being. 1 Studies indicate ashwagandha possesses anti-inflammatory, antitumor, antistress, antiantioxidant, anxiolytic, adaptogen, memory enhancing, antiparkinsonian, antivenom, antitumor properties. Various other effects like immunomodulation, hypolipidemic, antibacterial, cardiovascular protection, sexual behaviour, tolerance and dependence have also been studied. It also appears to exert a positive influence on the endocrine, cardiopulmonary, and central nervous systems. The mechanisms of action for these properties are not fully understood. Toxicity studies reveal that ashwagandha appears to be a safe compound. [2] [3] Withania somnifera is in use for a very long time for all age groups and both sexes and even during pregnancy without any side effects. The pharmacological effects of the roots of WS are attributed to the presence of withanolides, a group of steroidal lactones. Its leaves are used in Ayurvedic and Unani systems for treatment of tumors and tubercular glands. A number of withanolide steroidal lactones have been isolated from the leaves of W. somnifera and exhibit antibacterial, anti-fungal and antitumor properties. Ashwagandha is used to calm the mind, relieve weakness and nervous exhaustion, build sexual energy and promote healthy sleep. It is also classified as an adaptogen. 4 
Literature Review
Only few bibliometric studies have been carried out on bibliometric assessment of individual medicinal plants research output in the past. However, not a single bibliometric study is available on Withania somnifera research output. However similar bibliometric studies were pub-lished on some of the individual medicinal plants include Aloe Vera, 5 Azadrachta indica, 6 Curcuma longa, 7 Glycyrrhiza glabre, 8 Nigella sativa, 9 Ocimum Santum, 10 Phyllanthis emblica 11 and Tinospora Cordifolia. 12 
OBJECTIVES
The study examines research performance, in terms of quantitative and qualitative indicators on Withania somnifera plant during 22 years (1997) (1998) (1999) (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) (2013) (2014) (2015) (2016) , based on publications covered and indexed in Scopus database. Its objectives are: (i) to study the growth and distribution of global literature on Withania somnifera, (ii) to examine the scientometric profile and characteristics of the 10 most productive countries, 15 most productive organizations and to 15 most productive authors, (iii) To study the distribution of publication output by broad subject areas and identification of significant keywords, (iv) To identify the medium of communication and the bibliographic characteristics of global highly cited publications on Withania somnifera.
METHODOLOGY
Withania somnifera global publications of top 10 most productive countries were sourced from Scopus international database (http://www.scopus.com), using two keywords "ashwaganda" or "Withania somnifera" for the years 1995-2018. The "Keyword" and "Article Title" tags (as shown in search string below) were searched for the two keywords restricting the hit to the period 1995-2018 in "date range" tag. The statement becomes the main search string. The main search string was further restricted to individual 10 countries in "country" tag one by one for obtaining publication data of these countries. On further restricting global search string by "subject area tag", "country tag", "source title tag", "journal title name" and "affiliation tag", statistics on distribution of publications by subject, collaborating countries, author-wise, organization-wise and journalwise, etc. were obtained. Citation data was obtained from date of publication till 25 January 2018. Select bibliometric indicators have been used to study the performance of global Withania somnifera research. (KEY("ashwaganda" or "withania somnifera") OR TITLE(ashwaganda or "withania somnifera")) AND PUBYEAR > 1994 AND PUBYEAR < 2019 (Table 1) . Of the total global publications output on Withania somnifera, 80.13% (1609) appeared as articles, 14.44% (290) as editorials (0.55%), notes (0.50%), erratum (0.30%), articles in press (0.15%) and retracted (0.05%). reviews, 1.49% (30) as book chapters and the rest below 1%: Conference papers and letters (0.85% each), short surveys (0.70%),
ANALYSIS

Top 10 Most Productive Countries on Withania somnifera Research
The global research output in the field of Withania somnifera research had originated from as many as 72 countries during 1995-2018, of which, 64 published 1-10 publications each in 24 years, 13 countries 11-50 publications each and 2 countries 228-1414 publications each. The top 10 most productive countries in Withania somnifera research contributed 27 to 1414 publications each during 1995-2008 ( Table 2 ). The top 10 most productive countries in Withania somnifera research accounted for more than 100% global publication share and more than 100% citation share during 1995-2018. Country-wise, the global publication share of top 10 countries varied widely 1.34% to 70.42% during 1995-2018, with India accounting for the highest publication share (70.42%), followed much behind by USA (11.35%) and other eight countries having global publication share from 1.34% to 4.03% during 1995-2018. Only four of top 10 countries scored relative citation index above the world average of 1.01: U.K. (2.48), USA (1.80), Germany (1.69) and South Korea (1.08) during 1997-16. India has though emerged as one of the world leader in Withania somnifera research, its performance in terms of relative citation index (0.84) has below the world average.
International Collaboration
The international collaborative output of top 10 most productive countries on Withania somnifera research as a national share in the countrywise output varied widely from 12.16% to 75.51%, with average share of 22.31% during 1995-2018. The highest international collaborative publication share comes from Saudi Arabia (75.51%), followed by Germany (70.37%), Japan (56.25%), U.K. (51.52%), South Korea (50.00%), South Africa (40.63%), USA (39.47%), Pakistan (38.27%), Iran (22.58%) and India (12.16%) during 1995-2018. Most surprisingly, India's international collaborative share in its national output in Withania somnifera research has been the lowest among the top 10 countries.
Subject-Wise Distribution of Research Output
The global Withania somnifera research output published during 1995-2018 is distributed across nine sub-fields (as identified in Scopus database classification), with pharmacology, toxicology and pharmaceutics accounting for the highest publications share (42.33%), followed by biochemistry, genetics and molecular biology (32.42%), medicine (30.73%), agricultural and biological Sciences (25.45%) and other 5 sub-fields contribution varying from 2.69% to 7.57% during 1995-2018. Its activity index, which computes change in research activity in the discipline over time 1995-2006 to 2007-2018 (world average activity index of a given subject is taken as 100), witnessed increase in biochemistry, genetics and molecular biology (from 84.12 to 103.50), agricultural and biological Sciences (from 63.87 to 107.97), immunology and microbiology (from 67.21 to 107.24), neurosciences (from 82.66 to 103.83), environment sciences (from 84.60 to 103.40) and veterinary science (from 61.46 to 108.50), as against decrease in pharmacology, toxicology and pharmaceutics (from 120.40 to 95.50), medicine (from 105.79 to 98.72) and chemistry (from 116.46 to 96.37). Neuorosciences, among various subjects registered the highest citations impact per publication of 25.17 CPP, followed by biochemistry, genetics and molecular biology (22.01), medicine (21.17), pharmacology, toxicology and pharmaceutics (19.67), chemistry (18.64), agricultural and biological sciences (13.14), immunology and microbiology (12.32) and environmental science (10.01) during 1995-2018 ( Table 3 ). (Table 6 ).
Profile of Top 15 Most Productive Global Organizations
Medium of Research Communication
Significant Keywords
Around 134 significant keywords having potential to identify comparative research trends in Withania somnifera research studies including pharmacological properties and medicinal uses were discovered from the global literature on Withania somnifera. These keywords are listed in Table 7 in the decreasing order of the frequency of their occurrence in the literature during 1995-2018. Of the total Withania somnifera global research output, 68 publications registered high citations, in the range of 100 to 601 citations per publication, and collectively these highly cited publications received a total of 11582 citations, averaging to 170.32 citations per publication. These 68 highly cited publications involved the participation of 289 personal authors and 127 research organizations in total across globe and were published in 37 journals. The leading journals were Journal of Ethnopharmacology (16 publications), Phytomedicine (4 papers), Cancer Research and Life Sciences (3 papers each), etc. Among 68 highly cited publications, the largest participation was seen from India (36 publications), followed by the USA (17 publications), Japan (4 publications), Germany and U.K. (3 publications each), etc. Conclusively, this research study reveals that developing countries (India India, Pakistan, Saudi Arabia, South Africa and Iran) dominate in Withania somnifera search more in terms of quantity of research (with 79.79% global publications share and averaging 11.13 citations per paper), developed countries (USA, Japan, South Korea, U.K. and Germany) dominate instead more in terms of quality of research (with 20.21% global share and averaging 32.17 citation per paper). It concludes that higher priority may be assigned to plant based research in developing countries, particularly in India. In developing countries, the R&D effort needs to be stepped up with comparatively higher investment in terms of both financial and manpower outputs. There is also need to increase the international collaboration, with a view to increase their research output and improved research impact. Conclude that Withania somnifera may be useful in many ailments, including arthritis and other musculoskeletal disorders, stress-induced nervous exhaustion, and hypertension. There are a few preliminary studies available on the effects of WS on the immune system, central nervous system, hemopoetic system, and general growth promotion to form a basis for further studies but not enough evidence to provide a firm scientific basis for definitive therapeutic uses. Preliminary studies have found various constituents of Withania somnifera exhibit a variety of therapeutic effects with little or no associated toxicity. These results are very encouraging and indicate this herb should be studied more extensively to confirm these results and reveal other potential therapeutic effects. Clinical trials using ashwagandha for a variety of conditions should also be conducted.
Highly Cited Publications
